Poszler Alexander, Nguyen Evelyn, Braunisch Matthias Christoph, Rasch Sebastian, Abdelhafez Mohamed, Ulrich Jörg, Wiessner Johannes, Schmid Roland M, Lahmer Tobias
Department of Gastroenterology, Krankenhaus Agatharied, Hausham, Germany.
Faculty of Medicine, Technical University of Munich, Munich, Germany.
Scand J Gastroenterol. 2022 Dec;57(12):1417-1422. doi: 10.1080/00365521.2022.2089860. Epub 2022 Jun 30.
Risk stratification for the need for therapeutic endoscopy and prediction of mortality in patients with upper gastrointestinal bleeding (UGIB) can be assessed by several scores. However, current scores are not validated for variceal bleeding and Intensive Care Unit (ICU) patients. The aim of this study was to evaluate potential parameters for the prediction of UGIB and patient outcomes.
In this monocenter retrospective observational study, data from all esophagogastroduodenoscopies (EGD) between November 2014 and February 2020 with suspected hemorrhage in our ICU were evaluated.
Out of 345 included EGD, 42.3% of UGIB was diagnosed. 51.9% needed endoscopic intervention. Overall, 52.3% of included patients with UGIB died. Logistic regression showed that preceding variceal or non-variceal UGIB ( < .001), serum lactate ( = .001), heart rate (HR) ( = .005), and blood transfusions ( = .001) were significant predictors of UGIB. Previous UGIB ( < .001), male sex ( = .015), known varices ( < .001), serum albumin ( = .19) and use of catecholamines ( = .040) were significant predictors for the need of endoscopic intervention. Higher mortality was significantly associated with the usage of steroids ( < .001), malignant preconditions ( = .021), serum albumin ( = .020) and prolonged PTT (partial thromboplastin time) ( = .001).
We were able to identify additional parameters that had previously not been included in existing scores to predict the risk of UGIB, the need for therapeutic endoscopy and mortality in ICU patients. Therefore, an extension of these scores is necessary. Further validation of identified parameters in multicenter trials is needed to improve risk scores for ICU patients.
上消化道出血(UGIB)患者治疗性内镜检查需求的风险分层及死亡率预测可通过多种评分来评估。然而,目前的评分尚未在静脉曲张出血患者和重症监护病房(ICU)患者中得到验证。本研究的目的是评估预测UGIB及患者预后的潜在参数。
在这项单中心回顾性观察研究中,对2014年11月至2020年2月期间我们ICU内所有疑似出血的食管胃十二指肠镜检查(EGD)数据进行了评估。
在纳入的345例EGD中,42.3%被诊断为UGIB。51.9%需要内镜干预。总体而言,纳入的UGIB患者中有52.3%死亡。逻辑回归显示,既往静脉曲张或非静脉曲张性UGIB(<0.001)、血清乳酸(=0.001)、心率(HR)(=0.005)和输血(=0.001)是UGIB的显著预测因素。既往UGIB(<0.001)、男性(=0.015)、已知静脉曲张(<0.001)、血清白蛋白(=0.19)和使用儿茶酚胺(=0.040)是内镜干预需求的显著预测因素。较高的死亡率与使用类固醇(<0.001)、恶性基础疾病(=0.021)、血清白蛋白(=0.020)和延长的活化部分凝血活酶时间(PTT)(=0.001)显著相关。
我们能够识别出先前现有评分中未包含的额外参数,以预测ICU患者UGIB的风险、治疗性内镜检查的需求和死亡率。因此,有必要扩展这些评分。需要在多中心试验中对已识别的参数进行进一步验证,以改进ICU患者的风险评分。